Skip to main content
. 2018 Dec 31;14:335. doi: 10.2147/IJN.S197654

Table 1.

Treatment Beginning of treatment (×1010) End of treatment (×1010)
MDA-MB-453 bearing mice
Control 1.15 1.73
Liposome + free trastuzumab 0.877 2.53
Immunoliposome 1.70 1.72
MDA-MB-231 bearing mice
Control 1.19 5.96
Liposome + free trastuzumab 1.49 3.88
Immunoliposome 1.38 3.44